Jump To Section:

Identification Taxonomy Ontology Physical properties Spectra Biological properties Concentrations Links References XML

Record Information

Version

5.0

Status

Predicted

Creation Date

2021-03-31 19:28:03 UTC

Update Date

2022-10-24 19:45:17 UTC

HMDB ID

HMDB0241657

Secondary Accession Numbers

None

Metabolite Identification

Common Name

(3E)-Tiglylcarnitine

Description

(3E)-Tiglylcarnitine is an acylcarnitine. More specifically, it is an (3E)-pent-3-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279 ). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review (PMID: 35710135 ), acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (3E)-Tiglylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine (3E)-Tiglylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980 ). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. In particular (3E)-Tiglylcarnitine is elevated in the blood or plasma of individuals with beta ketothiolase deficiency/acat1 gene mutation (PMID: 27264805 , PMID: 14518824 , PMID: 3435793 ), and ECHS1 deficiency (PMID: 31908952 ). It is also decreased in the blood or plasma of individuals with familial mediterranean fever (PMID: 29900937 ), carcinoma, lewis lung (PMID: 30839735 ), metabolic syndrome, type 2 diabetes mellitus, and cardiovascular diseases (PMID: 24710945 ). Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643 ). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available (PMID: 35710135 ).

Structure

MOL 3D MOL SDF 3D SDF PDB 3D PDB SMILES InChI

HMDB0241657
     RDKit          3D
(3E)-Tiglylcarnitine
 38 37  0  0  0  0  0  0  0  0999 V2000
    4.8780    0.2911    0.3655 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8073    0.9017    1.1477 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6736    1.2778    0.6074 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4345    1.0910   -0.8395 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2386    0.2016   -1.0349 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7595   -0.1112   -2.1215 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6206   -0.3114    0.1147 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4976   -1.1525    0.1042 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1519   -2.5668    0.5260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3099   -3.4799    0.5354 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8722   -3.8770    1.6212 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8658   -3.9672   -0.6351 O   0  0  0  0  0  1  0  0  0  0  0  0
   -1.7089   -0.5961    0.7625 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2237    0.6136    0.1871 N   0  0  0  0  0  4  0  0  0  0  0  0
   -3.5141    0.9329    0.8269 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3145    1.7327    0.4318 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4691    0.5716   -1.2233 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6922   -0.7998    0.2140 H   0  0  0  0  0  0  0  0  0  0  0  0
    5.8554    0.3570    0.9214 H   0  0  0  0  0  0  0  0  0  0  0  0
    5.0400    0.8495   -0.5664 H   0  0  0  0  0  0  0  0  0  0  0  0
    3.9695    1.0436    2.2322 H   0  0  0  0  0  0  0  0  0  0  0  0
    1.9134    1.7277    1.2466 H   0  0  0  0  0  0  0  0  0  0  0  0
    3.2745    0.7426   -1.4251 H   0  0  0  0  0  0  0  0  0  0  0  0
    2.1453    2.0968   -1.2415 H   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7409   -1.2610   -1.0041 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.3695   -2.5606    1.5287 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.6054   -3.0156   -0.1546 H   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5543   -1.3142    0.7959 H   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4783   -0.3823    1.8487 H   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2011    0.0914    0.7430 H   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9469    1.7871    0.2544 H   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3862    1.2426    1.8618 H   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5590    1.3845    1.1609 H   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8569    2.1269   -0.4941 H   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8645    2.5541    0.9413 H   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4984    0.9757   -1.4664 H   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4743   -0.4477   -1.6597 H   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7885    1.2497   -1.8168 H   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
  8 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 14 17  1  0
  1 18  1  0
  1 19  1  0
  1 20  1  0
  2 21  1  0
  3 22  1  0
  4 23  1  0
  4 24  1  0
  8 25  1  0
  9 26  1  0
  9 27  1  0
 13 28  1  0
 13 29  1  0
 15 30  1  0
 15 31  1  0
 15 32  1  0
 16 33  1  0
 16 34  1  0
 16 35  1  0
 17 36  1  0
 17 37  1  0
 17 38  1  0
M  CHG  2  12  -1  14   1
M  END


  Mrv1652303312121282D          

 17 16  0  0  0  0            999 V2000
   -1.3184   -1.2375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6039   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6039    0.0000    0.0000 O   0  5  0  0  0  0  0  0  0  0  0  0
    0.1105   -1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8250   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5395   -1.2375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5395   -2.0625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8250   -2.4750    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2539   -2.4750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9684   -2.0625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6829   -2.4750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3974   -2.0625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8250    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5395    0.4125    0.0000 N   0  3  0  0  0  0  0  0  0  0  0  0
    1.9520   -0.3020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1270    1.1270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2539    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0  0  0  0
  2  3  1  0  0  0  0
  2  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  2  0  0  0  0
  7  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 11 12  1  4  0  0  0
  5 13  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 14 16  1  0  0  0  0
 14 17  1  0  0  0  0
M  CHG  2   3  -1  14   1
M  END
> <DATABASE_ID>
HMDB0241657

> <DATABASE_NAME>
hmdb

> <SMILES>
CC=CCC(=O)OC(CC([O-])=O)C[N+](C)(C)C

> <INCHI_IDENTIFIER>
InChI=1S/C12H21NO4/c1-5-6-7-12(16)17-10(8-11(14)15)9-13(2,3)4/h5-6,10H,7-9H2,1-4H3

> <INCHI_KEY>
FKCFAOUKERDIER-UHFFFAOYSA-N

> <FORMULA>
C12H21NO4

> <MOLECULAR_WEIGHT>
243.303

> <EXACT_MASS>
243.14705816

> <JCHEM_ACCEPTOR_COUNT>
3

> <JCHEM_ATOM_COUNT>
38

> <JCHEM_AVERAGE_POLARIZABILITY>
25.835810939822167

> <JCHEM_BIOAVAILABILITY>
1

> <JCHEM_DONOR_COUNT>
0

> <JCHEM_FORMAL_CHARGE>
0

> <JCHEM_GHOSE_FILTER>
0

> <JCHEM_IUPAC>
3-(pent-3-enoyloxy)-4-(trimethylazaniumyl)butanoate

> <JCHEM_LOGP>
-3.2186291174717443

> <JCHEM_MDDR_LIKE_RULE>
0

> <JCHEM_NUMBER_OF_RINGS>
0

> <JCHEM_PHYSIOLOGICAL_CHARGE>
0

> <JCHEM_PKA_STRONGEST_ACIDIC>
4.295143098227813

> <JCHEM_PKA_STRONGEST_BASIC>
-7.103904872500037

> <JCHEM_POLAR_SURFACE_AREA>
66.43

> <JCHEM_REFRACTIVITY>
87.5823

> <JCHEM_ROTATABLE_BOND_COUNT>
8

> <JCHEM_RULE_OF_FIVE>
1

> <JCHEM_TRADITIONAL_IUPAC>
3-(pent-3-enoyloxy)-4-(trimethylammonio)butanoate

> <JCHEM_VEBER_RULE>
0

$$$$

HMDB0241657
     RDKit          3D
(3E)-Tiglylcarnitine
 38 37  0  0  0  0  0  0  0  0999 V2000
    4.8780    0.2911    0.3655 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8073    0.9017    1.1477 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6736    1.2778    0.6074 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4345    1.0910   -0.8395 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2386    0.2016   -1.0349 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7595   -0.1112   -2.1215 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6206   -0.3114    0.1147 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4976   -1.1525    0.1042 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1519   -2.5668    0.5260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3099   -3.4799    0.5354 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8722   -3.8770    1.6212 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8658   -3.9672   -0.6351 O   0  0  0  0  0  1  0  0  0  0  0  0
   -1.7089   -0.5961    0.7625 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2237    0.6136    0.1871 N   0  0  0  0  0  4  0  0  0  0  0  0
   -3.5141    0.9329    0.8269 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3145    1.7327    0.4318 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4691    0.5716   -1.2233 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6922   -0.7998    0.2140 H   0  0  0  0  0  0  0  0  0  0  0  0
    5.8554    0.3570    0.9214 H   0  0  0  0  0  0  0  0  0  0  0  0
    5.0400    0.8495   -0.5664 H   0  0  0  0  0  0  0  0  0  0  0  0
    3.9695    1.0436    2.2322 H   0  0  0  0  0  0  0  0  0  0  0  0
    1.9134    1.7277    1.2466 H   0  0  0  0  0  0  0  0  0  0  0  0
    3.2745    0.7426   -1.4251 H   0  0  0  0  0  0  0  0  0  0  0  0
    2.1453    2.0968   -1.2415 H   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7409   -1.2610   -1.0041 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.3695   -2.5606    1.5287 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.6054   -3.0156   -0.1546 H   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5543   -1.3142    0.7959 H   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4783   -0.3823    1.8487 H   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2011    0.0914    0.7430 H   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9469    1.7871    0.2544 H   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3862    1.2426    1.8618 H   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5590    1.3845    1.1609 H   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8569    2.1269   -0.4941 H   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8645    2.5541    0.9413 H   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4984    0.9757   -1.4664 H   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4743   -0.4477   -1.6597 H   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7885    1.2497   -1.8168 H   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
  8 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 14 17  1  0
  1 18  1  0
  1 19  1  0
  1 20  1  0
  2 21  1  0
  3 22  1  0
  4 23  1  0
  4 24  1  0
  8 25  1  0
  9 26  1  0
  9 27  1  0
 13 28  1  0
 13 29  1  0
 15 30  1  0
 15 31  1  0
 15 32  1  0
 16 33  1  0
 16 34  1  0
 16 35  1  0
 17 36  1  0
 17 37  1  0
 17 38  1  0
M  CHG  2  12  -1  14   1
M  END

HEADER    PROTEIN                                 31-MAR-21   NONE
TITLE     NULL                                                        
COMPND    NULL                                                        
SOURCE    NULL                                                        
KEYWDS    NULL                                                        
EXPDTA    NULL                                                        
AUTHOR    Marvin                                                      
REVDAT   1   31-MAR-21         0                                  
HETATM    1  O   UNK     0      -2.461  -2.310   0.000  0.00  0.00           O+0
HETATM    2  C   UNK     0      -1.127  -1.540   0.000  0.00  0.00           C+0
HETATM    3  O   UNK     0      -1.127   0.000   0.000  0.00  0.00           O-1
HETATM    4  C   UNK     0       0.206  -2.310   0.000  0.00  0.00           C+0
HETATM    5  C   UNK     0       1.540  -1.540   0.000  0.00  0.00           C+0
HETATM    6  O   UNK     0       2.874  -2.310   0.000  0.00  0.00           O+0
HETATM    7  C   UNK     0       2.874  -3.850   0.000  0.00  0.00           C+0
HETATM    8  O   UNK     0       1.540  -4.620   0.000  0.00  0.00           O+0
HETATM    9  C   UNK     0       4.207  -4.620   0.000  0.00  0.00           C+0
HETATM   10  C   UNK     0       5.541  -3.850   0.000  0.00  0.00           C+0
HETATM   11  C   UNK     0       6.875  -4.620   0.000  0.00  0.00           C+0
HETATM   12  C   UNK     0       8.208  -3.850   0.000  0.00  0.00           C+0
HETATM   13  C   UNK     0       1.540   0.000   0.000  0.00  0.00           C+0
HETATM   14  N   UNK     0       2.874   0.770   0.000  0.00  0.00           N+1
HETATM   15  C   UNK     0       3.644  -0.564   0.000  0.00  0.00           C+0
HETATM   16  C   UNK     0       2.104   2.104   0.000  0.00  0.00           C+0
HETATM   17  C   UNK     0       4.207   1.540   0.000  0.00  0.00           C+0
CONECT    1    2                                                            
CONECT    2    1    3    4                                                  
CONECT    3    2                                                            
CONECT    4    2    5                                                       
CONECT    5    4    6   13                                                  
CONECT    6    5    7                                                       
CONECT    7    6    8    9                                                  
CONECT    8    7                                                            
CONECT    9    7   10                                                       
CONECT   10    9   11                                                       
CONECT   11   10   12                                                       
CONECT   12   11                                                            
CONECT   13    5   14                                                       
CONECT   14   13   15   16   17                                             
CONECT   15   14                                                            
CONECT   16   14                                                            
CONECT   17   14                                                            
MASTER        0    0    0    0    0    0    0    0   17    0   32    0
END

COMPND    HMDB0241657
HETATM    1  C1  UNL     1       4.878   0.291   0.365  1.00  0.00           C  
HETATM    2  C2  UNL     1       3.807   0.902   1.148  1.00  0.00           C  
HETATM    3  C3  UNL     1       2.674   1.278   0.607  1.00  0.00           C  
HETATM    4  C4  UNL     1       2.435   1.091  -0.840  1.00  0.00           C  
HETATM    5  C5  UNL     1       1.239   0.202  -1.035  1.00  0.00           C  
HETATM    6  O1  UNL     1       0.760  -0.111  -2.121  1.00  0.00           O  
HETATM    7  O2  UNL     1       0.621  -0.311   0.115  1.00  0.00           O  
HETATM    8  C6  UNL     1      -0.498  -1.152   0.104  1.00  0.00           C  
HETATM    9  C7  UNL     1      -0.152  -2.567   0.526  1.00  0.00           C  
HETATM   10  C8  UNL     1      -1.310  -3.480   0.535  1.00  0.00           C  
HETATM   11  O3  UNL     1      -1.872  -3.877   1.621  1.00  0.00           O  
HETATM   12  O4  UNL     1      -1.866  -3.967  -0.635  1.00  0.00           O1-
HETATM   13  C9  UNL     1      -1.709  -0.596   0.763  1.00  0.00           C  
HETATM   14  N1  UNL     1      -2.224   0.614   0.187  1.00  0.00           N1+
HETATM   15  C10 UNL     1      -3.514   0.933   0.827  1.00  0.00           C  
HETATM   16  C11 UNL     1      -1.314   1.733   0.432  1.00  0.00           C  
HETATM   17  C12 UNL     1      -2.469   0.572  -1.223  1.00  0.00           C  
HETATM   18  H1  UNL     1       4.692  -0.800   0.214  1.00  0.00           H  
HETATM   19  H2  UNL     1       5.855   0.357   0.921  1.00  0.00           H  
HETATM   20  H3  UNL     1       5.040   0.849  -0.566  1.00  0.00           H  
HETATM   21  H4  UNL     1       3.970   1.044   2.232  1.00  0.00           H  
HETATM   22  H5  UNL     1       1.913   1.728   1.247  1.00  0.00           H  
HETATM   23  H6  UNL     1       3.274   0.743  -1.425  1.00  0.00           H  
HETATM   24  H7  UNL     1       2.145   2.097  -1.241  1.00  0.00           H  
HETATM   25  H8  UNL     1      -0.741  -1.261  -1.004  1.00  0.00           H  
HETATM   26  H9  UNL     1       0.369  -2.561   1.529  1.00  0.00           H  
HETATM   27  H10 UNL     1       0.605  -3.016  -0.155  1.00  0.00           H  
HETATM   28  H11 UNL     1      -2.554  -1.314   0.796  1.00  0.00           H  
HETATM   29  H12 UNL     1      -1.478  -0.382   1.849  1.00  0.00           H  
HETATM   30  H13 UNL     1      -4.201   0.091   0.743  1.00  0.00           H  
HETATM   31  H14 UNL     1      -3.947   1.787   0.254  1.00  0.00           H  
HETATM   32  H15 UNL     1      -3.386   1.243   1.862  1.00  0.00           H  
HETATM   33  H16 UNL     1      -0.559   1.384   1.161  1.00  0.00           H  
HETATM   34  H17 UNL     1      -0.857   2.127  -0.494  1.00  0.00           H  
HETATM   35  H18 UNL     1      -1.865   2.554   0.941  1.00  0.00           H  
HETATM   36  H19 UNL     1      -3.498   0.976  -1.466  1.00  0.00           H  
HETATM   37  H20 UNL     1      -2.474  -0.448  -1.660  1.00  0.00           H  
HETATM   38  H21 UNL     1      -1.788   1.250  -1.817  1.00  0.00           H  
CONECT    1    2   18   19   20
CONECT    2    3    3   21
CONECT    3    4   22
CONECT    4    5   23   24
CONECT    5    6    6    7
CONECT    7    8
CONECT    8    9   13   25
CONECT    9   10   26   27
CONECT   10   11   11   12
CONECT   13   14   28   29
CONECT   14   15   16   17
CONECT   15   30   31   32
CONECT   16   33   34   35
CONECT   17   36   37   38
END

HMDB0241657
     RDKit          3D
(3E)-Tiglylcarnitine
 38 37  0  0  0  0  0  0  0  0999 V2000
    4.8780    0.2911    0.3655 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8073    0.9017    1.1477 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6736    1.2778    0.6074 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4345    1.0910   -0.8395 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2386    0.2016   -1.0349 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7595   -0.1112   -2.1215 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.6206   -0.3114    0.1147 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4976   -1.1525    0.1042 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1519   -2.5668    0.5260 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3099   -3.4799    0.5354 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8722   -3.8770    1.6212 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8658   -3.9672   -0.6351 O   0  0  0  0  0  1  0  0  0  0  0  0
   -1.7089   -0.5961    0.7625 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2237    0.6136    0.1871 N   0  0  0  0  0  4  0  0  0  0  0  0
   -3.5141    0.9329    0.8269 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3145    1.7327    0.4318 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4691    0.5716   -1.2233 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6922   -0.7998    0.2140 H   0  0  0  0  0  0  0  0  0  0  0  0
    5.8554    0.3570    0.9214 H   0  0  0  0  0  0  0  0  0  0  0  0
    5.0400    0.8495   -0.5664 H   0  0  0  0  0  0  0  0  0  0  0  0
    3.9695    1.0436    2.2322 H   0  0  0  0  0  0  0  0  0  0  0  0
    1.9134    1.7277    1.2466 H   0  0  0  0  0  0  0  0  0  0  0  0
    3.2745    0.7426   -1.4251 H   0  0  0  0  0  0  0  0  0  0  0  0
    2.1453    2.0968   -1.2415 H   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7409   -1.2610   -1.0041 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.3695   -2.5606    1.5287 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.6054   -3.0156   -0.1546 H   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5543   -1.3142    0.7959 H   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4783   -0.3823    1.8487 H   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2011    0.0914    0.7430 H   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9469    1.7871    0.2544 H   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3862    1.2426    1.8618 H   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5590    1.3845    1.1609 H   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8569    2.1269   -0.4941 H   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8645    2.5541    0.9413 H   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4984    0.9757   -1.4664 H   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4743   -0.4477   -1.6597 H   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7885    1.2497   -1.8168 H   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
  8 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 14 17  1  0
  1 18  1  0
  1 19  1  0
  1 20  1  0
  2 21  1  0
  3 22  1  0
  4 23  1  0
  4 24  1  0
  8 25  1  0
  9 26  1  0
  9 27  1  0
 13 28  1  0
 13 29  1  0
 15 30  1  0
 15 31  1  0
 15 32  1  0
 16 33  1  0
 16 34  1  0
 16 35  1  0
 17 36  1  0
 17 37  1  0
 17 38  1  0
M  CHG  2  12  -1  14   1
M  END

View in JSmol View NMR Assignments View Stereo Labels

Synonyms

Not Available

Chemical Formula

C₁₂H₂₁NO₄

Average Molecular Weight

243.303

Monoisotopic Molecular Weight

243.14705816

IUPAC Name

3-(pent-3-enoyloxy)-4-(trimethylazaniumyl)butanoate

Traditional Name

3-(pent-3-enoyloxy)-4-(trimethylammonio)butanoate

CAS Registry Number

Not Available

SMILES

CC=CCC(=O)OC(CC([O-])=O)C[N+](C)(C)C

InChI Identifier

InChI=1S/C12H21NO4/c1-5-6-7-12(16)17-10(8-11(14)15)9-13(2,3)4/h5-6,10H,7-9H2,1-4H3

InChI Key

FKCFAOUKERDIER-UHFFFAOYSA-N

Chemical Taxonomy

Description

Belongs to the class of organic compounds known as acyl carnitines. These are organic compounds containing a fatty acid with the carboxylic acid attached to carnitine through an ester bond.

Kingdom

Organic compounds

Super Class

Lipids and lipid-like molecules

Class

Fatty Acyls

Sub Class

Fatty acid esters

Direct Parent

Acyl carnitines

Alternative Parents

Substituents

Acyl-carnitine
Dicarboxylic acid or derivatives
Tetraalkylammonium salt
Quaternary ammonium salt
Carboxylic acid salt
Carboxylic acid ester
Carboxylic acid
Carboxylic acid derivative
Organic nitrogen compound
Organic oxygen compound
Organopnictogen compound
Organic oxide
Hydrocarbon derivative
Organic salt
Organooxygen compound
Organonitrogen compound
Carbonyl group
Amine
Aliphatic acyclic compound

Molecular Framework

Aliphatic acyclic compounds

External Descriptors

Not Available

Ontology

Physiological effect

Health effect

Cancer

Breast cancer (PMID: 35710135)

Diabetes mellitus type 2 (PMID: 35710135)
Celiac disease (PMID: 35710135)
Inflammatory bowel disease (PMID: 35710135)

Circulatory system disorder

Cardiac disorder

Cardiovascular disease (PMID: 35710135)
Heart failure (PMID: 35710135)

Renal system and urinary system

Renal disorder

Renal cell carcinoma (PMID: 35710135)

Disposition

Biological location

Cell

All cells and tissues (PMID: 35710135)

Non-excretory biofluid

Biofluid or Excreta

Blood (PMID: 35710135)

Excreta

Biofluid or Excreta

Urine (PMID: 35710135)

Cellular substructure

cytoplasm (PMID: 35710135)
mitochondrion matrix (PMID: 35710135)

Organelle

peroxisome (PMID: 35710135)

Process

Not Available

Role

Biological role

Energy source (PMID: 35710135)

Industrial application

Pharmaceutical industry

Biomarker

Physical Properties

State

Not Available

Experimental Molecular Properties

Property	Value	Reference
Melting Point	Not Available	Not Available
Boiling Point	Not Available	Not Available
Water Solubility	Not Available	Not Available
LogP	Not Available	Not Available

Experimental Chromatographic Properties

Not Available

Predicted Molecular Properties

Property	Value	Source
logP	-3.2	ChemAxon
pKa (Strongest Acidic)	4.3	ChemAxon
pKa (Strongest Basic)	-7.1	ChemAxon
Physiological Charge	0	ChemAxon
Hydrogen Acceptor Count	3	ChemAxon
Hydrogen Donor Count	0	ChemAxon
Polar Surface Area	66.43 Å²	ChemAxon
Rotatable Bond Count	8	ChemAxon
Refractivity	87.58 m³·mol⁻¹	ChemAxon
Polarizability	25.84 Å³	ChemAxon
Number of Rings	0	ChemAxon
Bioavailability	Yes	ChemAxon
Rule of Five	Yes	ChemAxon
Ghose Filter	No	ChemAxon
Veber's Rule	No	ChemAxon
MDDR-like Rule	No	ChemAxon

Predicted Chromatographic Properties

Predicted Collision Cross Sections

Predictor	Adduct Type	CCS Value (Å²)	Reference
DeepCCS	[M+H]+	150.223	30932474
DeepCCS	[M-H]-	147.862	30932474
DeepCCS	[M-2H]-	180.806	30932474
DeepCCS	[M+Na]+	156.314	30932474

Predicted Kovats Retention Indices

Underivatized

Metabolite	SMILES	Kovats RI Value	Column Type	Reference
(3E)-Tiglylcarnitine	CC=CCC(=O)OC(CC([O-])=O)C[N+](C)(C)C	2149.3	Standard polar	33892256
(3E)-Tiglylcarnitine	CC=CCC(=O)OC(CC([O-])=O)C[N+](C)(C)C	1380.4	Standard non polar	33892256
(3E)-Tiglylcarnitine	CC=CCC(=O)OC(CC([O-])=O)C[N+](C)(C)C	1583.6	Semi standard non polar	33892256

Spectra

GC-MS Spectra

Spectrum Type	Description	Splash Key	Deposition Date	Source	View
Predicted GC-MS	Predicted GC-MS Spectrum - (3E)-Tiglylcarnitine GC-MS (Non-derivatized) - 70eV, Positive	Not Available	2021-10-12	Wishart Lab	View Spectrum

MS/MS Spectra

Spectrum Type	Description	Splash Key	Deposition Date	Source	View
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum - (3E)-Tiglylcarnitine 10V, Positive-QTOF	Not Available	2021-04-06	Wishart Lab	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum - (3E)-Tiglylcarnitine 20V, Positive-QTOF	Not Available	2021-04-06	Wishart Lab	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum - (3E)-Tiglylcarnitine 40V, Positive-QTOF	Not Available	2021-04-06	Wishart Lab	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum - (3E)-Tiglylcarnitine 10V, Positive-QTOF	splash10-0006-0090000000-e78bd389593472138484	2021-09-23	Wishart Lab	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum - (3E)-Tiglylcarnitine 20V, Positive-QTOF	splash10-000l-9050000000-1bb9d023b199264c5fe7	2021-09-23	Wishart Lab	View Spectrum
Predicted LC-MS/MS	Predicted LC-MS/MS Spectrum - (3E)-Tiglylcarnitine 40V, Positive-QTOF	splash10-000i-9000000000-e9262cbaff8cb4ad0ba6	2021-09-23	Wishart Lab	View Spectrum

NMR Spectra

Spectrum Type	Description	Deposition Date	Source	View
Predicted 1D NMR	¹H NMR Spectrum (1D, 100 MHz, D₂O, predicted)	2021-09-25	Wishart Lab	View Spectrum
Predicted 1D NMR	¹³C NMR Spectrum (1D, 100 MHz, D₂O, predicted)	2021-09-25	Wishart Lab	View Spectrum
Predicted 1D NMR	¹H NMR Spectrum (1D, 1000 MHz, D₂O, predicted)	2021-09-25	Wishart Lab	View Spectrum
Predicted 1D NMR	¹³C NMR Spectrum (1D, 1000 MHz, D₂O, predicted)	2021-09-25	Wishart Lab	View Spectrum
Predicted 1D NMR	¹H NMR Spectrum (1D, 200 MHz, D₂O, predicted)	2021-09-25	Wishart Lab	View Spectrum
Predicted 1D NMR	¹³C NMR Spectrum (1D, 200 MHz, D₂O, predicted)	2021-09-25	Wishart Lab	View Spectrum
Predicted 1D NMR	¹H NMR Spectrum (1D, 300 MHz, D₂O, predicted)	2021-09-25	Wishart Lab	View Spectrum
Predicted 1D NMR	¹³C NMR Spectrum (1D, 300 MHz, D₂O, predicted)	2021-09-25	Wishart Lab	View Spectrum
Predicted 1D NMR	¹H NMR Spectrum (1D, 400 MHz, D₂O, predicted)	2021-09-25	Wishart Lab	View Spectrum
Predicted 1D NMR	¹³C NMR Spectrum (1D, 400 MHz, D₂O, predicted)	2021-09-25	Wishart Lab	View Spectrum
Predicted 1D NMR	¹H NMR Spectrum (1D, 500 MHz, D₂O, predicted)	2021-09-25	Wishart Lab	View Spectrum
Predicted 1D NMR	¹³C NMR Spectrum (1D, 500 MHz, D₂O, predicted)	2021-09-25	Wishart Lab	View Spectrum
Predicted 1D NMR	¹H NMR Spectrum (1D, 600 MHz, D₂O, predicted)	2021-09-25	Wishart Lab	View Spectrum
Predicted 1D NMR	¹³C NMR Spectrum (1D, 600 MHz, D₂O, predicted)	2021-09-25	Wishart Lab	View Spectrum
Predicted 1D NMR	¹H NMR Spectrum (1D, 700 MHz, D₂O, predicted)	2021-09-25	Wishart Lab	View Spectrum
Predicted 1D NMR	¹³C NMR Spectrum (1D, 700 MHz, D₂O, predicted)	2021-09-25	Wishart Lab	View Spectrum
Predicted 1D NMR	¹H NMR Spectrum (1D, 800 MHz, D₂O, predicted)	2021-09-25	Wishart Lab	View Spectrum
Predicted 1D NMR	¹³C NMR Spectrum (1D, 800 MHz, D₂O, predicted)	2021-09-25	Wishart Lab	View Spectrum
Predicted 1D NMR	¹H NMR Spectrum (1D, 900 MHz, D₂O, predicted)	2021-09-25	Wishart Lab	View Spectrum
Predicted 1D NMR	¹³C NMR Spectrum (1D, 900 MHz, D₂O, predicted)	2021-09-25	Wishart Lab	View Spectrum

Biological Properties

Cellular Locations

Not Available

Biospecimen Locations

Not Available

Tissue Locations

Not Available

Pathways

Name	SMPDB/PathBank	KEGG
Acylcarnitine (3E)-Tiglylcarnitine		Not Available

Normal Concentrations

Not Available

Abnormal Concentrations

Not Available

Associated Disorders and Diseases

Disease References

None

Associated OMIM IDs

None

External Links

DrugBank ID

Not Available

Phenol Explorer Compound ID

Not Available

FooDB ID

Not Available

KNApSAcK ID

Not Available

Chemspider ID

Not Available

KEGG Compound ID

Not Available

BioCyc ID

Not Available

BiGG ID

Not Available

Wikipedia Link

Not Available

METLIN ID

Not Available

PubChem Compound

Not Available

PDB ID

Not Available

ChEBI ID

Not Available

Food Biomarker Ontology

Not Available

VMH ID

Not Available

MarkerDB ID

Not Available

Good Scents ID

Not Available

References

Synthesis Reference

Not Available

Material Safety Data Sheet (MSDS)

Not Available

General References

Fukao T, Zhang GX, Sakura N, Kubo T, Yamaga H, Hazama A, Kohno Y, Matsuo N, Kondo M, Yamaguchi S, Shigematsu Y, Kondo N: The mitochondrial acetoacetyl-CoA thiolase (T2) deficiency in Japanese patients: urinary organic acid and blood acylcarnitine profiles under stable conditions have subtle abnormalities in T2-deficient patients with some residual T2 activity. J Inherit Metab Dis. 2003;26(5):423-31. [PubMed:14518824 ]
Millington DS, Roe CR, Maltby DA: Characterization of new diagnostic acylcarnitines in patients with beta-ketothiolase deficiency and glutaric aciduria type I using mass spectrometry. Biomed Environ Mass Spectrom. 1987 Dec;14(12):711-6. [PubMed:3435793 ]
Violante S, Ijlst L, Ruiter J, Koster J, van Lenthe H, Duran M, de Almeida IT, Wanders RJ, Houten SM, Ventura FV: Substrate specificity of human carnitine acetyltransferase: Implications for fatty acid and branched-chain amino acid metabolism. Biochim Biophys Acta. 2013 Jun;1832(6):773-9. doi: 10.1016/j.bbadis.2013.02.012. Epub 2013 Feb 24. [PubMed:23485643 ]
Blazenovic I, Kind T, Sa MR, Ji J, Vaniya A, Wancewicz B, Roberts BS, Torbasinovic H, Lee T, Mehta SS, Showalter MR, Song H, Kwok J, Jahn D, Kim J, Fiehn O: Structure Annotation of All Mass Spectra in Untargeted Metabolomics. Anal Chem. 2019 Feb 5;91(3):2155-2162. doi: 10.1021/acs.analchem.8b04698. Epub 2019 Jan 16. [PubMed:30608141 ]
FRITZ IB: Action of carnitine on long chain fatty acid oxidation by liver. Am J Physiol. 1959 Aug;197:297-304. doi: 10.1152/ajplegacy.1959.197.2.297. [PubMed:13825279 ]
Makarova E, Makrecka-Kuka M, Vilks K, Volska K, Sevostjanovs E, Grinberga S, Zarkova-Malkova O, Dambrova M, Liepinsh E: Decreases in Circulating Concentrations of Long-Chain Acylcarnitines and Free Fatty Acids During the Glucose Tolerance Test Represent Tissue-Specific Insulin Sensitivity. Front Endocrinol (Lausanne). 2019 Dec 17;10:870. doi: 10.3389/fendo.2019.00870. eCollection 2019. [PubMed:31920980 ]
Kiykim E, Aktuglu Zeybek AC, Barut K, Zubarioglu T, Cansever MS, Alsancak S, Kasapcopur O: Screening of Free Carnitine and Acylcarnitine Status in Children With Familial Mediterranean Fever. Arch Rheumatol. 2016 Mar 10;31(2):133-138. doi: 10.5606/ArchRheumatol.2016.5696. eCollection 2016 Jun. [PubMed:29900937 ]
Wen P, Chen Z, Wang G, Su Z, Zhang X, Tang G, Cui D, Liu X, Li C: [Analysis of clinical phenotype and ACAT1 gene mutation in a family affected with beta-ketothiolase deficiency]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2016 Jun;33(3):286-91. doi: 10.3760/cma.j.issn.1003-9406.2016.03.002. [PubMed:27264805 ]
Pajares S, Lopez RM, Gort L, Argudo-Ramirez A, Marin JL, Gonzalez de Aledo-Castillo JM, Garcia-Villoria J, Arranz JA, Del Toro M, Tort F, Ugarteburu O, Casellas MD, Fernandez R, Ribes A: An incidental finding in newborn screening leading to the diagnosis of a patient with ECHS1 mutations. Mol Genet Metab Rep. 2020 Jan 2;22:100553. doi: 10.1016/j.ymgmr.2019.100553. eCollection 2020 Mar. [PubMed:31908952 ]
Wu H, Chen Y, Li Z, Liu X: Untargeted metabolomics profiles delineate metabolic alterations in mouse plasma during lung carcinoma development using UPLC-QTOF/MS in MS(E) mode. R Soc Open Sci. 2018 Sep 19;5(9):181143. doi: 10.1098/rsos.181143. eCollection 2018 Sep. [PubMed:30839735 ]
Yu ZR, Ning Y, Yu H, Tang NJ: A HPLC-Q-TOF-MS-based urinary metabolomic approach to identification of potential biomarkers of metabolic syndrome. J Huazhong Univ Sci Technolog Med Sci. 2014 Apr;34(2):276-283. doi: 10.1007/s11596-014-1271-7. Epub 2014 Apr 8. [PubMed:24710945 ]
Yu D, Zhou L, Xuan Q, Wang L, Zhao X, Lu X, Xu G: Strategy for Comprehensive Identification of Acylcarnitines Based on Liquid Chromatography-High-Resolution Mass Spectrometry. Anal Chem. 2018 May 1;90(9):5712-5718. doi: 10.1021/acs.analchem.7b05471. Epub 2018 Apr 20. [PubMed:29651844 ]
Yan X, Markey SP, Marupaka R, Dong Q, Cooper BT, Mirokhin YA, Wallace WE, Stein SE: Mass Spectral Library of Acylcarnitines Derived from Human Urine. Anal Chem. 2020 May 5;92(9):6521-6528. doi: 10.1021/acs.analchem.0c00129. Epub 2020 Apr 23. [PubMed:32271007 ]
Zuniga A, Li L: Ultra-high performance liquid chromatography tandem mass spectrometry for comprehensive analysis of urinary acylcarnitines. Anal Chim Acta. 2011 Mar 9;689(1):77-84. doi: 10.1016/j.aca.2011.01.018. Epub 2011 Jan 18. [PubMed:21338760 ]
Dambrova M, Makrecka-Kuka M, Kuka J, Vilskersts R, Nordberg D, Attwood MM, Smesny S, Sen ZD, Guo AC, Oler E, Tian S, Zheng J, Wishart DS, Liepinsh E, Schioth HB: Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials. Pharmacol Rev. 2022 Jul;74(3):506-551. doi: 10.1124/pharmrev.121.000408. [PubMed:35710135 ]

Showing metabocard for (3E)-Tiglylcarnitine (HMDB0241657)

MOL for HMDB0241657 ((3E)-Tiglylcarnitine)

3D MOL for HMDB0241657 ((3E)-Tiglylcarnitine)

3D SDF for HMDB0241657 ((3E)-Tiglylcarnitine)

3D-SDF for HMDB0241657 ((3E)-Tiglylcarnitine)

PDB for HMDB0241657 ((3E)-Tiglylcarnitine)

3D PDB for HMDB0241657 ((3E)-Tiglylcarnitine)

SMILES for HMDB0241657 ((3E)-Tiglylcarnitine)

INCHI for HMDB0241657 ((3E)-Tiglylcarnitine)

Structure for HMDB0241657 ((3E)-Tiglylcarnitine)

3D Structure for HMDB0241657 ((3E)-Tiglylcarnitine)

Predicted Collision Cross Sections

Predicted Kovats Retention Indices

Underivatized

GC-MS Spectra

MS/MS Spectra

NMR Spectra